🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

India's Aurobindo Pharma says director arrested by Enforcement Directorate

Published 11/10/2022, 04:38 AM
Updated 11/10/2022, 04:41 AM
© Reuters.
PERP
-

BENGALURU (Reuters) - India's federal financial crime agency has arrested P. Sarath Chandra Reddy, a director of Aurobindo Pharma Ltd, the drugmaker said in an exchange filing on Thursday.

Several media reports also said French spirits giant Pernod Ricard (EPA:PERP)'s Benoy Babu, an executive at its India business, was also arrested by the Enforcement Directorate (ED) under sections of the Prevention of Money Laundering Act (PMLA).

Pernod Ricard did not immediately respond to a Reuters request for comment, while Aurobindo did not respond to an email seeking details on the arrest.

Reddy's arrest is not connected with the operations of Aurobindo or its subsidiaries, the company said in a separate filing.

Shares in Aurobindo, which makes a range of medicines from antibacterials to antidepressants, fell over 7%.

Reddy, a business administration graduate, belongs to the promoter group of the company, which has manufacturing plants in the United States, Brazil and Portugal, according to its website.

Media reports also said Reddy and Babu were arrested in connection with the ED's investigation into the alleged irregularities in the now-scrapped liquor policy of the Delhi government.

The ED had, last month, raided several liquor companies, suppliers and distributors in a money laundering investigation, according to media reports.

 

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.